# Effects of TCM on Beta-cell Function and Insulin Resistance in High Risk Chinese Individuals for T2D (TCM_PDiab_P01)

> **NCT04441216** · NA · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 40 (estimated)

## Conditions studied

- Prediabetic State

## Interventions

- **OTHER:** Rhizoma Coptidis, Radix Astragali and Flos Lonicerae
- **OTHER:** Rhizoma Coptidis, Radix Astragali and Flos Lonicerae, Ophiopogonis Radix

## Key facts

- **NCT ID:** NCT04441216
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-02
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04441216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04441216, "Effects of TCM on Beta-cell Function and Insulin Resistance in High Risk Chinese Individuals for T2D (TCM_PDiab_P01)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04441216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*